Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

6.90
Delayed Data
As of Jun 24
 -0.16 / -2.27%
Today’s Change
3.70
Today|||52-Week Range
9.25
+20.63%
Year-to-Date

Today’s Trading

Previous close7.06
Today’s open6.87
Day’s range6.10 - 6.99
Volume1,049,126
Average volume (3 months)61,353
Market cap$155.8M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-11.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+33.56%
P/E ratioNM
Price/Sales5.42
Price/Book3.25

Competitors

 Today’s
change
Today’s
% change
INNLInnocoll Holdings PL...-0.30-5.45%
SYNSynthetic Biologics ...-0.06-3.41%
ZFGNZafgen Inc-0.43-6.85%
NBRVNabriva Therapeutics...-0.12-1.65%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateJuly 29, 2016
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$20.1M
Annual profit (last year)-$12.8M
Net profit margin-63.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers

Search for Jobs